Study Supplement: OEA for Gulf War Illness

Phase-Based Progress Estimates
Gulf War Illness
Oleoylethanolamide (OEA) - DietarySupplement
Any Age
All Sexes
What conditions do you have?

Study Summary

This trial is studying OEA to see if it can help treat symptoms in people with Gulf War Illness.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 6 Secondary · Reporting Duration: 10 weeks

10 weeks
Changes in cognition (neuropsychological)
Changes in fatigue
Changes in immune biomarker profiles
Changes in lipid biomarker profiles
Changes in mood
Changes in quality of life

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Study Supplement: OEA
1 of 2
1 of 2
Active Control
Non-Treatment Group

52 Total Participants · 2 Treatment Groups

Primary Treatment: Study Supplement: OEA · Has Placebo Group · N/A

PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: DietarySupplement
Study Supplement: OEA
ActiveComparator Group · 1 Intervention: Oleoylethanolamide (OEA) · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 10 weeks

Who is running the clinical trial?

Roskamp Institute Inc.Lead Sponsor
5 Previous Clinical Trials
374 Total Patients Enrolled
2 Trials studying Gulf War Illness
128 Patients Enrolled for Gulf War Illness
United States Department of DefenseFED
767 Previous Clinical Trials
202,353 Total Patients Enrolled
11 Trials studying Gulf War Illness
668 Patients Enrolled for Gulf War Illness
Laila Abdullah, PhDPrincipal InvestigatorThe Roskamp Insitute
2 Previous Clinical Trials
128 Total Patients Enrolled
2 Trials studying Gulf War Illness
128 Patients Enrolled for Gulf War Illness
Andrew Keegan, MDPrincipal InvestigatorThe Roskamp Insitute
1 Previous Clinical Trials
52 Total Patients Enrolled
1 Trials studying Gulf War Illness
52 Patients Enrolled for Gulf War Illness

Eligibility Criteria

Age Any Age · All Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are both male and female, of all ethnic groups, and all ages.
Veteran has chronic multisymptom illness.
You are 50.0kg (110lbs) or more.\n
You are of reproductive age and willing to use an acceptable form of birth control for 30 days after the last dose.
You were deployed to the Gulf War between August 1990 and August 1991.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 24th, 2021

Last Reviewed: October 28th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.